Risk factors, management, and outcomes of hemolysis, elevated liver enzymes, and low platelets syndrome and elevated liver enzymes, low platelets syndrome

Obstetrics and Gynecology

Volumn 123, Issue 3, 2014, Pages 618-627

  Fitzpatrick, Kathryn E ^a   Hinshaw, Kim ^a   Kurinczuk, Jennifer J ^a   Knight, Marian ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; CESAREAN SECTION; FEMALE; GREAT BRITAIN; HELLP SYNDROME; HUMANS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; ODDS RATIO; PREGNANCY; RISK FACTORS; TREATMENT OUTCOME; WATCHFUL WAITING;

EID: 84894412846     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000140     Document Type: Article

References (28)

1. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142:159-67.
2. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing Am J Obstet Gynecol 1990;162:311-6.
3. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004;103:981-91.
4. Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001;322: 1089-93.
5. Martin JN Jr, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999;180:1373-84.
6. Gasem T, Al Jama FE, Burshaid S, Rahman J, Al Suleiman SA, Rahman MS. Maternal and fetal outcome of pregnancy complicated by HELLP syndrome. J Matern Fetal Neonatal Med 2009;22:1140-3.
7. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy Childbirth 2009;9:8.
8. Knight M, Kurinczuk JJ, Tuffnell D, Brocklehurst P. The UK Obstetric Surveillance System for rare disorders of pregnancy. BJOG 2005;112:263-5.
9. Northern Ireland Statistics and Research Agency. Registrar general annual report 2011. Belfast (UK): Northern Ireland Statistics and Research Agency; 2012.
10. General Register Office for Scotland. Vital events reference tables 2011. Edinburgh (UK): General Register Office for Scotland; 2012.
11. Office for National Statistics. Birth summary tables, England and Wales 2011. Newport (UK): Office for National Statistics; 2012.
12. Cole TJ, Williams AF, Wright CM; RCPCH Growth Chart Expert Group. Revised birth centiles for weight, length and head circumference in the UK-WHO growth charts. Ann Hum Biol 2011;38:7-11.
13. Pan H, Cole TJ. LMSgrowth, a Microsoft Excel add-in to access growth referencs based on the LMS method. Version 2.77. Available at: http://www.healthforallchildren.co.uk/. 2012. Retrieved on July 1, 2013.
14. Department of Health. Comprehensive critical care: a review of adult critical care services. London (UK): Department of Health; 2000.
15. Aloizos S, Seretis C, Liakos N, Aravosita P, Mystakelli C, Kanna E, et al. HELLP syndrome: understanding and management of a pregnancy-specific disease. J Obstet Gynaecol 2013; 33:331-7.
16. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169: 1000-6.
17. Knight M. Studies using routine data versus specific data collection: what can we learn about the epidemiology of eclampsia and the impact of changes in management of gestational hypertensive disorders Pregnancy Hypertens, An Int J Women's Cardiovasc Health 2011;1:109-16.
18. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365:785-99.
19. Dekker GA. Risk factors for preeclampsia. Clin Obstet Gynecol 1999;42:422-35.
20. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005;330:565.
21. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. The Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD004454. doi: 10.1002/14651858. CD004454. pub2.
22. Royal College of Obstetricians and Gynaecologists. Green-top guideline no. 7: antenatal corticosteroids to reduce neonatal morbidity and morality. London (UK): RCOG; 2010.
23. van Pampus MG, Wolf H, Ilsen A, Treffers PE. Maternal outcome following temporizing management of the (H)ELLP syndrome. Hypertens Pregnancy 2000;19:211-20.
24. Roelofsen AC, van Pampus MG, Aarnoudse JG. The HELLPsyndrome; maternal-fetal outcome and follow up of infants. J Perinat Med 2003;31:201-8.
25. Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996;175:460-4.
26. Martin JN Jr, Brewer JM, Wallace K, Sunesara I, Canizaro A, Blake PG, et al. HELLP syndrome and composite major maternal morbidity: importance of Mississippi classification system. J Matern Fetal Neonatal Med 2013;26:1201-6.
27. Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L, Sibai BM. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter Am J Obstet Gynecol 1999;180:221-5.
28. van Pampus MG, Wolf H, Westenberg SM, van der Post JA, Bonsel GJ, Treffers PE. Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 1998;76:31-6.